The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) Survey: Implications of vaginal discomfort in postmenopausal women and in male partners

Journal of Sexual Medicine

Volumn 10, Issue 9, 2013, Pages 2232-2241

  Nappi, Rossella E ^a   Kingsberg, Sheryl ^b   Maamari, Ricardo ^c   Simon, James ^d  

^a UNIVERSITY OF PAVIA   (Italy)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NOVO NORDISK INC   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Atrophy; Discomfort; Local Estrogen Therapy; Male Partner; Postmenopausal; Vaginal Dryness

Indexed keywords

ARTICLE; CANADA; CLINICAL ASSESSMENT; DENMARK; DYSPAREUNIA; EMOTION; ERECTILE DYSFUNCTION; ESTROGEN THERAPY; FEMALE; FINLAND; FRANCE; GENDER; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; INTIMACY; ITALY; MAJOR CLINICAL STUDY; MALE; NORWAY; POSTMENOPAUSE; PRIORITY JOURNAL; SELF ESTEEM; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SEXUALITY; SWEDEN; UNITED KINGDOM; UNITED STATES; VAGINA ATROPHY; VAGINAL DISCOMFORT;

ATROPHY; DISCOMFORT; LOCAL ESTROGEN THERAPY; MALE PARTNER; POSTMENOPAUSAL; VAGINAL DRYNESS;

AGED; ATROPHY; CANADA; COMMUNICATION; DYSPAREUNIA; EMOTIONS; ERECTILE DYSFUNCTION; ESTROGEN REPLACEMENT THERAPY; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; POSTMENOPAUSE; SELF CONCEPT; SEXUAL BEHAVIOR; SEXUAL PARTNERS; UNITED STATES; VAGINAL DISEASES;

EID: 84883553526     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12235     Document Type: Article

References (41)

1. Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med 2005;2:154-165.
2. Calleja-Agius J, Brincat MP. Urogenital atrophy. Climacteric 2009;12:279-285.
3. Nappi RE, Lachowsky M. Menopause and sexuality: Prevalence of symptoms and impact on quality of life. Maturitas 2009;63:138-141.
4. Parsons MA, Obermeyer CM. Women's midlife health across cultures: DAMES comparative analysis. Menopause 2007;14:760-768.
5. Obermeyer CM, Reher D, Alcala LC, Price K. The menopause in Spain: Results of the DAMES (Decisions At MEnopause) study. Maturitas 2005;52:190-198.
6. Nappi RE, Kokot-Kierepa M. Vaginal health: Views, insights & attitudes (VIVA)-Results from an international survey. Climacteric 2012;15:36-44.
7. Nappi RE, Kokot-Kierepa M. Women's voices in the menopause: Results from an international survey on vaginal atrophy. Maturitas 2010;67:233-238.
8. Bachmann GA, Leiblum SR, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol 1989;73:425-427.
9. Sturdee DW, Panay N; International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509-522.
10. Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative. Maturitas 2004;49:292-303.
11. Levine K, Williams R, Harmann K. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008;15:661-666.
12. Nappi RE, Polatti F. The use of estrogen therapy in women's sexual functioning (CME). J Sex Med 2009;6:603-616; quiz 618-9.
13. Ibe C, Simon JA. Vulvovaginal atrophy: Current and future therapies (CME). J Sex Med 2010;7:1042-1050; quiz 1051.
14. Krychman ML. Vaginal estrogens for the treatment of dyspareunia. J Sex Med 2011;8:666-674.
15. Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005;84:174-180.
16. Bachmann GA, Leiblum SR. Sexuality in sexagenarian women. Maturitas 1991;13:43-50.
17. Landau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762-774.
18. Kao A, Binik YM, Amsel R, Funaro D, Leroux N, Khalifé S. Biopsychosocial predictors of postmenopausal dyspareunia: The role of steroid hormones, vulvovaginal atrophy, cognitive-emotional factors, and dyadic adjustment. J Sex Med 2012;9:2066-2076.
19. Nappi RE, Albani F, Santamaria V, Tonani S, Magri F, Martini E, Chiovato L, Polatti F. Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause. Maturitas 2010;67:78-83.
20. Leiblum SR, Hayes RD, Wanser RA, Nelson JS. Vaginal dryness: A comparison of prevalence and interventions in 11 countries. J Sex Med 2009;6:2425-2433.
21. Ettinger B, Hait H, Reape KZ, Shu H. Measuring symptom relief in studies of vaginal and vulvar atrophy: The most bothersome symptom approach. Menopause 2008;15:885-889.
22. Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med 2009;6:2133-2142.
23. Gass ML, Cochrane BB, Larson JC, Manson JE, Barnabei VM, Brzyski RG, Lane DS, LaValleur J, Ockene JK, Mouton CP, Barad DH. Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative. Menopause 2011;18:1160-1171.
24. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Juliá MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52:S46-52.
25. Avis NE, Brockwell S, Randolph JF Jr, Shen S, Cain VS, Ory M, Greendale GA. Longitudinal changes in sexual functioning as women transition through menopause: Results from the Study of Women's Health Across the Nation. Menopause 2009;16:442-452.
26. North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause 2012;19:257-271.
27. Sturdee DW, Pines A; International Menopause Society Writing Group, Archer DF, Baber RJ, Barlow D, Birkhäuser MH, Brincat M, Cardozo L, de Villiers TJ, Gambacciani M, Gompel AA, Henderson VW, Kluft C, Lobo RA, MacLennan AH, Marsden J, Nappi RE, Panay N, Pickar JH, Robinson D, Simon J, Sitruk-Ware RL, Stevenson JC. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302-320.
28. North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14:355-369; quiz 370-1.
29. Wyeth. REVEAL REvealing Vaginal Effects At mid-Life: Surveys of postmenopausal women and health care professionals who treat postmenopausal women. Available at: http://www.revealsurvey.com/pdf/reveal-survey-results.pdf (accessed April 6, 2012).
30. Kingsberg S, Krychman ML, Wysocki S. Results of the REVIVE survey. Abstract presented at ISSWHS, 2013.
31. Goldstein I. Recognizing and treating urogenital atrophy in postmenopausal women. J Womens Health (Larchmt) 2010;19:425-432.
32. Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000;61:3090-3096.
33. Fisher W, Rosen R, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: The female experience of men's attitudes to life events and sexuality (F.E.M.A.L.E.S.) study. J Sex Med 2005;2:675-684.
34. Mehta A, Bachmann G. Vulvovaginal complaints. Clin Obstet Gynecol 2008;51:549-555.
35. Chedraui P, Perez-Lopez FR, San Miguel G, Avila C. Assessment of sexuality among middle-aged women using the Female Sexual Function Index. Climacteric 2009;12:213-221.
36. Shabsigh R, Anastasiades A, Cooper KL, Rutman MP. Female sexual dysfunction, voiding symptoms and depression: Common findings in partners of men with erectile dysfunction. World J Urol 2006;24:653-656.
37. Oberg K, Sjögren Fugl-Meyer KS. On Swedish women's distressing sexual dysfunctions: Some concomitant conditions and life satisfaction. J Sex Med 2005;2:169-180.
38. Fisher WA, Rosen RC, Eardley I, Niederberger C, Nadel A, Kaufman J, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: Understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med 2004;1:150-160.
39. Montorsi F, Althof SE. Partner responses to sildenafil citrate (Viagra) treatment of erectile dysfunction. Urology 2004;63:762-767.
40. Fisher W, Rosen R, Mollen M, Brock G, Karlin G, Pommerville P, Bangerter K, Bandel TJ, Derogatis LR; Vardenafil Study Group. Improving the sexual quality of life of couples affected by erectile dysfunction: A double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005;2:699-708.
41. Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples II: Association of female partner characteristics with male partner ED treatment seeking and phosphodiesterase type 5 inhibitor utilization. J Sex Med 2009;6:3111-3124.